MYRISK HEREDITARY CANCER TEST holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 10 (Medical Devices) with 1 filings. The WikiTrademarks Expansion Score is 1/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed June 14, 2026
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is MYRISK HEREDITARY CANCER TEST filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Filing Activity by NICE Class
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 99006549 | MYRISK HEREDITARY CANCER TEST | Jan 17, 2025 | Pending | 010 Medical Devices | Myriad Genetics, Inc. |
Weekly visibility reports showing how ChatGPT mentions MYRISK HEREDITARY CANCER TEST, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: MYRISK HEREDITARY CANCER TEST trademark portfolio
What trademarks does MYRISK HEREDITARY CANCER TEST hold?
MYRISK HEREDITARY CANCER TEST holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 10 (Medical Devices). The most recent filings are registered to Myriad Genetics, Inc..
How many trademarks does MYRISK HEREDITARY CANCER TEST have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to MYRISK HEREDITARY CANCER TEST. The brand has been actively filing since January 2025. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does MYRISK HEREDITARY CANCER TEST file most often?
MYRISK HEREDITARY CANCER TEST's most active class is NICE Class 10 (Medical Devices), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the MYRISK HEREDITARY CANCER TEST trademark?
The most recent filings under the MYRISK HEREDITARY CANCER TEST mark are registered to Myriad Genetics, Inc.. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is MYRISK HEREDITARY CANCER TEST expanding into new categories?
The current WikiTrademarks Expansion Score for MYRISK HEREDITARY CANCER TEST is 1 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new MYRISK HEREDITARY CANCER TEST trademark filings?
Click the Watch Brand button at the top of this page to add MYRISK HEREDITARY CANCER TEST to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare MYRISK HEREDITARY CANCER TEST to another owner · Browse all NICE classes · Most valuable brands